Jason Rando | Tiberend Strategic Advisors |
Travis Mickle | President and CEO |
LaDuane Clifton | CFO |
Jonathan Aschoff | ROTH |
Good day, and thank you for standing by. Welcome to the KemPharm Second Quarter 2021 Results Conference Call [Operator Instructions]. I'd now like to hand the conference over to your speaker today, Jason Rando, with Tiberend Strategic Advisors. Please go ahead.
Good afternoon, and thank you for joining our call today to discuss KemPharm's second quarter 2021 financial and corporate results.